Medicare Enrolled
Dr. Vaibhav Verma, MD
Hematology & Oncology · Canfield, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Verma from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Verma?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Verma
Dr. Vaibhav Verma is a hematology & oncology specialist in Canfield, OH, with 17 years of NPI registration. Based on federal Medicare data, Dr. Verma performed 2,388 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Verma received a total of $11,244 from 83 pharmaceutical and/or device companies across 535 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Verma is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years of NPI registration
▲ Top 21% volume in OH
$11,244 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,388
Medicare services
Top 21% in OH for hematology & oncology
Not available
Unique patients (not deduplicated)
$36
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
386 | $60 | $105 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
366 | $8 | $10 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
357 | $8 | $33 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
218 | $61 | $110 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
214 | $10 | $50 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
138 | $100 | $225 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
125 | $87 | $175 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
119 | $11 | $65 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
89 | $13 | $45 |
| Iron level test | 88 | $6 | $48 |
| Transferrin level test A blood test that measures the amount of transferrin, a protein that binds to and transports iron in the body. |
88 | $12 | $35 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
60 | $94 | $275 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
56 | $118 | $250 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
30 | $18 | $55 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
30 | $4 | $15 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
24 | $15 | $45 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
2.5% high complexity
5.0% medium
92.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,244
Total received (2018-2024)
Avg $1,606/year across 7 years
Top 26% in OH for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
83
Companies
535
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,463
2023
$3,098
2022
$2,671
2021
$1,452
2020
$37
2019
$214
2018
$309
Payments by company (2024)
Eisai Inc.
$221
Novartis Pharmaceuticals Corporation
$209
PFIZER INC.
$203
AstraZeneca Pharmaceuticals LP
$193
Lilly USA, LLC
$173
Blueprint Medicines Corporation
$172
Merck Sharp & Dohme LLC
$155
Takeda Pharmaceuticals U.S.A., Inc.
$151
GlaxoSmithKline, LLC.
$132
Celgene Corporation
$131
Astellas Pharma US Inc
$128
ABBVIE INC.
$110
Janssen Biotech, Inc.
$110
E.R. Squibb & Sons, L.L.C.
$80
Amgen Inc.
$76
Genmab U.S., Inc.
$70
Gilead Sciences, Inc.
$70
Genentech USA, Inc.
$67
SOBI, INC
$58
Novo Nordisk Inc
$57
Acrotech Biopharma Inc.
$56
Pharmacosmos Therapeutics Inc.
$54
GENZYME CORPORATION
$52
Daiichi Sankyo Inc.
$52
TAIHO ONCOLOGY, INC.
$51
Incyte Corporation
$48
Tempus AI, Inc
$46
EMD Serono, Inc.
$43
SERVIER PHARMACEUTICALS LLC
$43
JAZZ PHARMACEUTICALS INC.
$41
Agios Pharmaceuticals, Inc.
$41
Kyowa Kirin, Inc.
$31
Alexion Pharmaceuticals, Inc.
$25
Tolmar, Inc.
$25
Biocon Biologics Inc
$24
Regeneron Healthcare Solutions, Inc.
$23
Octapharma USA, Inc.
$23
RECORDATI_RARE_DISEASES_INC.
$22
ARRAY BIOPHARMA INC
$22
Dendreon Pharmaceuticals LLC
$21
ADC Therapeutics America, Inc.
$20
Spectrum Pharmaceuticals Inc.
$18
Ipsen Biopharmaceuticals, Inc
$16
Karyopharm Therapeutics Inc.
$16
Apellis Pharmaceuticals, Inc.
$16
Azurity Pharmaceuticals, Inc.
$15
Emmaus Medical, Inc.
$15
PUMA BIOTECHNOLOGY, INC.
$15
Boehringer Ingelheim Pharmaceuticals, Inc.
$15
Rigel Pharmaceuticals, Inc.
$11
Top 3 companies account for 18.3% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$737
AstraZeneca Pharmaceuticals LP
$570
PFIZER INC.
$561
E.R. Squibb & Sons, L.L.C.
$523
Merck Sharp & Dohme LLC
$518
Janssen Biotech, Inc.
$479
Takeda Pharmaceuticals U.S.A., Inc.
$469
Celgene Corporation
$460
Amgen Inc.
$451
GlaxoSmithKline, LLC.
$357
Eisai Inc.
$353
Lilly USA, LLC
$343
Astellas Pharma US Inc
$343
Genentech USA, Inc.
$326
GENZYME CORPORATION
$311
Regeneron Healthcare Solutions, Inc.
$281
Blueprint Medicines Corporation
$273
Pharmacyclics LLC, An AbbVie Company
$185
ABBVIE INC.
$158
Incyte Corporation
$153
Pharmacyclics LLC, an AbbVie Company
$153
EMD Serono, Inc.
$145
AVEO Pharmaceuticals, Inc.
$143
ImmunoGen, Inc.
$130
Genmab U.S., Inc.
$109
Dendreon Pharmaceuticals LLC
$108
Gilead Sciences, Inc.
$103
Seagen Inc.
$97
Daiichi Sankyo Inc.
$93
Bayer HealthCare Pharmaceuticals Inc.
$88
Alexion Pharmaceuticals, Inc.
$85
Ipsen Biopharmaceuticals, Inc
$84
Octapharma USA, Inc.
$81
Boehringer Ingelheim Pharmaceuticals, Inc.
$77
EISAI INC.
$77
Pharmacosmos Therapeutics Inc.
$75
SOBI, INC
$72
ADC Therapeutics America, Inc.
$72
Karyopharm Therapeutics Inc.
$69
Rigel Pharmaceuticals, Inc.
$67
JAZZ PHARMACEUTICALS INC.
$65
TAIHO ONCOLOGY, INC.
$65
AbbVie Inc.
$59
Novo Nordisk Inc
$57
Acrotech Biopharma Inc.
$56
Stemline Therapeutics Inc.
$51
Tempus AI, Inc
$46
Biocon Biologics Inc
$46
Myriad Genetic Laboratories, Inc.
$44
SERVIER PHARMACEUTICALS LLC
$43
Kite Pharma, Inc.
$42
Acrotech Biopharma LLC
$41
Agios Pharmaceuticals, Inc.
$41
PUMA BIOTECHNOLOGY, INC.
$39
ARRAY BIOPHARMA INC
$39
BeiGene USA, Inc.
$39
Jazz Pharmaceuticals Inc.
$38
Exelixis Inc.
$37
G1 Therapeutics, Inc.
$37
CTI BioPharma Corp.
$34
MorphoSys, US Inc.
$33
TerSera Therapeutics LLC
$33
Merck Sharp & Dohme Corporation
$33
Sobi, Inc
$32
Emmaus Medical, Inc.
$32
Spectrum Pharmaceuticals Inc.
$32
Epizyme, Inc.,
$32
Kyowa Kirin, Inc.
$31
Global Blood Therapeutics, Inc.
$27
Myovant Sciences Inc.
$26
Tolmar, Inc.
$25
Acceleron Pharma, Inc.
$24
RECORDATI_RARE_DISEASES_INC.
$22
Mirati Therapeutics, Inc.
$21
Mylan Institutional Inc.
$20
Puma Biotechnology, Inc.
$20
EUSA Pharma (US) LLC
$19
Adaptive Biotechnologies Corporation
$18
Apellis Pharmaceuticals, Inc.
$16
Azurity Pharmaceuticals, Inc.
$15
Aveo Pharmaceuticals, Inc.
$13
Taiho Oncology, Inc.
$12
Dova Pharmaceuticals
$11
Top 3 companies account for 16.6% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · ALPROLIX · ALUNBRIG · AREXVY · AYVAKIT · Abraxane · Alecensa · BAVENCIO · BELEODAQ · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · COSELA · CYRAMZA · Columvi · DARZALEX · DOPTELET · Doptelet · ELIGARD · ELIQUIS · ELITEK · ENHERTU · ENJAYMO · ERLEADA · EVENITY · EXKIVITY · Elahere · Empaveli · Endari · Enhertu · Epkinly · FOTIVDA · FRUZAQLA · FULPHILA · Fabhalta · GAZYVA · GILOTRIF · HYQVIA · Halaven · Hulio · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MYRISK · NERLYNX · NINLARO · Neulasta · Nexavar · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Ogivri · Onivyde · Orserdu · PADCEV · PANZYGA · PIQRAY · PLUVICTO · PRECISETUMOR · PROMACTA · PROVENGE · PYRUKYND · Padcev · Phesgo · Pomalyst · Poteligeo · REBLOZYL · ROLVEDON · RYBREVANT · Reblozyl · Rezlidhia · SARCLISA · SCEMBLIX · SYLVANT · Stivarga · Sylvant · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tecentriq · Tibsovo · Tivdak · ULTOMIRIS · Ultomiris · VELCADE · VENCLEXTA · VERZENIO · VIVIMUSTA · VONJO · Vanflyta · Venclexta · Vonjo · XALKORI · XOSPATA · XPOVIO · XTANDI · Xospata · Xtandi · ZEJULA · ZEPZELCA · ZIIHERA · Zoladex · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
19
County median income
$55,576
Nearest hospital to ZIP centroid (approximate)
HMHP ST ELIZABETH BOARDMAN HEALTH CENTER
5.5 mi
5.5 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Verma is a clinical cardiology specialist, with above-average Medicare volume (top 21% in OH), with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Verma experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Verma performed 386 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Verma receive payments from pharmaceutical companies?
Yes. Dr. Verma received a total of $11,244 from 83 companies across 535 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Verma's costs compare to other hematology & oncology specialists in Canfield?
Dr. Verma's average Medicare payment per service is $36. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Verma) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Canfield
Browse hematology & oncology specialists in Canfield ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in OH
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in OH
Which OH hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology